UK Medicines Agency Wants ‘Up To Five Years’ Notice Of New Applications

The MHRA says that having a complete picture of all upcoming filings will allow it to ensure “consistent and predictable” timelines for assessments and identify “potentially transformative technologies” at an early stage.